GTBP
What one share of GT Biopharma holds
Pharmaceutical Preparations
GT Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2025-12-31.
| Profit | −$0.57 |
|---|---|
| Cash and investments | $0.27 |
| Book value | $0.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.00 | −$257.93 | $0.01 | −$9.72 | — | — |
| 2018 | — | −$154.77 | $0.02 | −$6.40 | — | $6.73 |
| 2020 | $0.00 | −$193.58 | — | −$49.68 | — | −$169.22 |
| 2021 | — | −$61.81 | — | −$16.63 | — | $20.50 |
| 2022 | — | −$19.66 | — | −$14.32 | — | $10.76 |
| 2023 | — | −$5.64 | — | −$6.57 | — | $5.41 |
| 2024 | — | −$6.94 | — | −$6.80 | — | −$0.75 |
| 2025 | — | −$6.68 | — | −$2.34 | — | $0.23 |